Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450, putative | 0.0086 | 1 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0086 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0086 | 1 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0086 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0086 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0086 | 1 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0086 | 1 | 1 |
Leishmania major | cytochrome p450-like protein | 0.0086 | 1 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0086 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = -15 % | Modulation of GABAA alpha1beta2gamma2S receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as modulation of GABA-induced chloride ion current at holding potential -70 mV at 100 uM by two-microelectrode voltage clamp assay relative to GABA-treated control | ChEMBL. | 24905252 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.